U.S. stocks fell broadly on Wednesday as inflation surged to 4.2% year-over-year and renewed U.S.-Iran tensions in the Strait of Hormuz drove oil prices up 3.3%. Technology stocks led losses amid valuation concerns, while energy stocks rallied. The Nasdaq 100 dropped 1.4%, the S&P 500 fell 0.9%, and the Dow declined 1.2%. Fed rate-hike odds incre...

Superstring Capital Management established a new $5.82 million position in Vir Biotechnology by acquiring 730,548 shares in Q1 2026. The investment appears to be a bet on upcoming clinical catalysts rather than current financials, with Vir expecting Phase 3 hepatitis delta data in Q4 2026 and pivotal Phase 3 oncology trials in 2027. Despite being...

Multiple large-cap stocks experienced significant declines last week due to earnings misses and disappointing guidance. The top losers included Rambus (down 28.47%), Summit Therapeutics (down 27.82%), and Teradyne (down 17.85%), with notable declines also from Roblox, Spotify, and Robinhood. Weak financial results and lowered forward guidance acr...

U.S. equities reached all-time highs on Friday as Apple's blowout Q2 earnings powered a broad technology rally. The S&P 500 advanced 0.7% to 7,262, while the Nasdaq 100 rose 1.1% to 27,743. Apple surged 5.1% on strong revenue and guidance, while software stocks like Atlassian, Twilio, and Reddit soared on earnings beats. Energy stocks declined as...

A wave of momentum swept through large-cap stocks during the week of April 13-17, 2026, with ten standout performers. Notable gainers include Avis Budget Group (71.48% jump driven by short squeeze), IonQ (62.86% surge following DARPA contract award), Oklo (33.35% rise on nuclear power narrative), Robinhood (33.22% gain from bullish analyst outloo...